THC Biomed Intl Ltd.

OTCPK:THCB.F Stock Report

Market Cap: US$2.3m

THC Biomed Intl Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on THC Biomed Intl's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Apr 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How THC Biomed Intl makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:THCB.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 232-420
31 Jan 232-320
31 Oct 222-320
31 Jul 222-320
30 Apr 222-320
31 Jan 223-420
31 Oct 213-620
31 Jul 213-620
30 Apr 213-620
31 Jan 212-520
31 Oct 203-220
31 Jul 203020
30 Apr 203-430
31 Jan 203-840
31 Oct 192-1350
31 Jul 191-1360
30 Apr 191-1250
31 Jan 191-740
31 Oct 181-1230
31 Jul 181-1230
30 Apr 181-1030
31 Jan 181-1120
31 Oct 170-120
31 Jul 170-110
30 Apr 170010
31 Jan 170110
31 Oct 160110
31 Jul 160-110
30 Apr 160-220
31 Jan 160-220
31 Oct 150-320
31 Jul 150-320
30 Apr 150-210
31 Jan 150-200
31 Oct 140000

Quality Earnings: Insufficient data to determine if THCB.F has high quality earnings.

Growing Profit Margin: Insufficient data to determine if THCB.F's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if THCB.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare THCB.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if THCB.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.

Return on Equity

High ROE: THCB.F has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/26 01:33
End of Day Share Price 2025/01/24 00:00
Earnings2023/04/30
Annual Earnings2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

THC Biomed Intl Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siddharth RajeevFundamental Research Corp.
Brian TangFundamental Research Corp.